Survival of a Patient with Anaplastic Thyroid Cancer Following Intensity-modulated Radiotherapy and Sunitinib - A Case Report

被引：0
|
作者：
Schoenfeld, Jonathan D. [1 ,3 ]
Odejide, Oreofe O. [2 ,4 ]
Wirth, Lori J. [2 ]
Chan, Annie W. [1 ]
机构：
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol, Boston, MA 02114 USA
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med Oncol, Boston, MA 02114 USA
[3] Harvard Radiat Oncol Program, Boston, MA USA
[4] Dana Farber Partners CancerCare Hematol Oncol Fel, Boston, MA USA
来源：
ANTICANCER RESEARCH | 2012年 / 32卷 / 05期
关键词：
Anaplastic thyroid carcinoma; chemoradiation; intensity-modulated radiation therapy (IMRT); sunitinib; case report; PROGNOSTIC-FACTORS; TREATMENT OUTCOMES; PHASE-II; CARCINOMA; SURGERY; TRIAL; RADIATION;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: Anaplastic: thyroid cancer has a very poor prognosis, especially in patients who have gross residual disease following resection. Case Report: We present the case of a patient with anaplastic thyroid cancer and a significant gross residual disease treated with intensity-modulated radiotherapy with concurrent chemotherapy and sunitinib who had a complete response and remains without evidence of disease more than 18 months after diagnosis. Conclusion: Chemoradiotherapy has an important role in the adjuvant treatment of anaplastic thyroid cancer in selected patients and should be considered when gross residual disease is present following resection. The combined use of radiotherapy and targeted biological agents such as sunitinib may warrant further investigation.
引用
收藏
页码：1743 / 1746
页数：4
相关论文
共 50 条
  • [1] Patterns of failure in anaplastic and differentiated thyroid carcinoma treated with intensity-modulated radiotherapy
    Vulpe, H.
    Kwan, J. Y. Y.
    McNiven, A.
    Brierley, J. D.
    Tsang, R.
    Chan, B.
    Goldstein, D. P.
    Le, L. W.
    Hope, A.
    Giuliani, M.
    CURRENT ONCOLOGY, 2017, 24 (03) : E226 - E232
  • [2] Feasibility of intensity-modulated radiotherapy for esophageal cancer in definite chemoradiotherapy
    Hsieh, He-Yuan
    Yeh, Hui-Ling
    Hsu, Chung-Ping
    Lin, Jin-Ching
    Chuang, Cheng-Yen
    Lin, Jai-Fu
    Chang, Chen-Fa
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2016, 79 (07) : 375 - 381
  • [3] Intensity-modulated radiotherapy for prostate cancer
    Fischer-Valuck, Ben W.
    Rao, Yuan James
    Michalski, Jeff M.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 (03) : 297 - 307
  • [4] A Case of Anaplastic Thyroid Cancer with Long-term Survival
    Koussis, Haralabos
    Maruzzo, Marco
    Scola, Annamaria
    Ide, Eric Casal
    Fassina, Ambrogio
    Marioni, Gino
    Lora, Ornella
    Corti, Luigi
    Karachontziti, Paraskevi
    Jirillo, Antonio
    ANTICANCER RESEARCH, 2010, 30 (04) : 1273 - 1278
  • [5] Radiotherapy for Anal Cancer Intensity-Modulated Radiotherapy and Future Directions
    Castaneda, Serguei A.
    Romak, Lindsay B.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 26 (03) : 467 - +
  • [6] Intensity-Modulated Radiotherapy Associated With Improved Survival Outcome in Anal Cancer
    Mohamed, Ahmed Allam
    Schlenter, Marsha
    Heinzel, Alexander
    Kintsler, Svetlana
    Eble, Michael J.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [7] Anaplastic Thyroid Cancer: a case report of a long term survival patient and review of literature data
    Ursino, S.
    Fiorica, F.
    Stefanelli, A.
    Pedriali, M.
    Colosimo, C.
    Cocuzza, P.
    Mazzotti, V.
    Taibi, R.
    Cartei, F.
    Greco, C.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (09) : 1368 - 1372
  • [8] A COMPARISON OF HELICAL INTENSITY-MODULATED RADIOTHERAPY, INTENSITY-MODULATED RADIOTHERAPY, AND 3D-CONFORMAL RADIATION THERAPY FOR PANCREATIC CANCER
    Poppe, Matthew M.
    Narra, Venkat
    Yue, Ning J.
    Zhou, Jinghao
    Nelson, Carl
    Jabbour, Salma K.
    MEDICAL DOSIMETRY, 2011, 36 (04) : 351 - 357
  • [9] Recurrence in region of spared parotid gland in patient receiving definitive intensity-modulated radiotherapy for nasopharyngeal cancer: A case report
    Autorino, Rosa
    Micciche, Francesco
    Dinapoli, Nicola
    Bussu, Francesco
    Balducci, Mario
    Mattiucci, Gian Carlo
    Galli, Jacopo
    Tartaglione, Tommaso
    Rufini, Vittoria
    Almadori, Giovanni
    Paludetti, Gaetano
    Valentini, Vincenzo
    ACTA ONCOLOGICA, 2012, 51 (08) : 1095 - U150
  • [10] Response to immunotherapy in a patient with anaplastic thyroid cancer A case report
    Zheng, Luming
    Li, Ling
    He, Qingqing
    Wang, Meng
    Ma, Yunhan
    Zhu, Jian
    Li, Yanchen
    Fu, Xiaokang
    Zhang, Yaxuan
    MEDICINE, 2021, 100 (32) : E26138
12345